What are public preferences for COVID-19 vaccine prioritization strategies across the globe?

An interesting new study by an international team of researchers describes the results of a novel survey that asked members of the public in a range of countries for their thoughts on prioritization measures for vaccination programs against coronavirus disease 2019 (COVID-19).

Though highly diverse, the sample population provided surprisingly similar answers, which indicates the need to take the public into account when determining how to roll out these vaccines.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The research team’s findings were recently released on the medRxiv* preprint server.

Public prioritization

The researchers surveyed over 15,500 people online in 13 countries to ask about how they would want the vaccines to be distributed. They asked the survey participants to assess provided descriptions of potential vaccine recipients, containing randomly assigned attributes.

The model used in this study – namely, conjoint modeling – has already been used successfully to reflect public views on healthcare, such as on influenza vaccination. The results are largely in line with decision making in the real-world setting. In the current survey, the responses dealt with how vaccines should be made available to people other than the respondents, which is an important departure from earlier uses of this method.

The responses showed that the public used a wide spectrum of characteristics to assign vaccine priorities. These included features such as the risk of being infected or of severe disease, as well as of spreading the disease widely. As such, age, the presence of comorbidities and occupation played a major role in the participants’ preferences in vaccine allocation.

However, the public priorities also included other less predictable factors, such as low-income groups, teaching and other key occupations even though not directly related to health, and non-essential workers who could not work from home.

Consistent preferences across national boundaries

Interestingly, public health vaccine priorities showed quite a marked difference from country to country, but the surveyed members of the public showed a consistent preference pattern across both countries and regions. These are also correlated with the age and income of the respondents, irrespective of their country.

Political preferences also did not appear to interfere with these priorities, which is encouraging, since it indicates that governmental policies tuned to these views would not divide countries.

Putting others first

The researchers observed that many of the participants put the perceived need of other, often dissimilar, vaccine recipients over their own interests. One striking example is how elderly people over 65 years, who are known to be at higher risk of severe disease and death following SARS-CoV-2 infection, often indicated that essential workers in many occupations should receive the vaccine first.

The motives in such allocations may be mixed, mingling a feeling of unselfish generosity, with a desire to decrease the numbers of potentially exposed individuals who could infect others, including the participants, or simply a desire for the world to return to normalcy as quickly as possible through optimal use of the vaccine.

However, these results unmistakably demonstrate that people, in general, can choose to have the most useful type of vaccination schedule without reference to their own personal need for protection from the pandemic.

Comparison with other research

Similar studies are few, but a recent Belgian survey showed that essential workers, those likely to spread the virus, and high-risk groups, were prioritized by the public. This study failed to show any evidence that the public wanted those over 60 years to receive the vaccine earlier.

Such comparisons across countries help us understand to what extent public opinions converge despite different geographical, economic and cultural settings.

Mismatch between vaccine policy and public opinion

The researchers point out that government policies on vaccine priorities show a much larger range of divergence across countries than do public opinions. The two do coincide in some areas, such as prioritizing those at high risk of death from SARS-CoV-2 infection.

However, most countries do not place similar stress on vaccinating those in key occupations such as teaching, though this was evidently a public priority.

The same mismatch was observed with respect to poorer sections of society and those workers in non-essential occupations who nonetheless have to go out of their homes for work. Such a firm emphasis on economically deprived segments of the population, or otherwise disadvantaged groups, has not been a feature of vaccine prioritization by any government anywhere in the world.

Public versus private distribution

Most of the respondents said they would prefer for the vaccine to be allocated only by the government. However, a significant minority said they would pay for the vaccine if it was privately distributed. Many also indicated they would be willing to pay for faster access, most of these being in low- and middle-income countries (India, Uganda, Brazil, Chile).

This trend should be taken into account when framing policies for private allocation, as this should not limit the availability of the vaccine for public vaccination programs. Instead, complementary public and private access should be planned to optimize the reach of the vaccines.

Simultaneously, such combined-access vaccination programs will allow the public to defray the cost as far as is feasible, while preventing injustice and corruption as far as possible.

Allocation Mechanism.
Allocation Mechanism.

Mandatory or voluntary vaccination?

The survey also reveals broad support for mandatory vaccination but at the same time considerable opposition by a significant proportion of the population, especially in the USA and the UK, and by most of the public in France. These countries should therefore take considerable care to communicate, persuade and execute vaccination programs and policies, in a way that convinces without alienating a large part of their people.

What are the implications?

The important role of the public as stockholders in any public vaccination program should not be disregarded, since public opinion is mostly based on values that should be reflected, or at least seriously considered, by policymakers.

The findings of this study “identify opportunities for policymakers, who have often struggled during the COVID-19 pandemic to meet their obligations to protect public health and the economy while simultaneously respecting the public will.”

Where there are major differences, and the government chooses unpopular policies for the sake of the broader good of the public, a recognition of such differences will help them communicate to the public with greater moral and persuasive force, enhancing the acceptance of vaccination programs against COVID-19.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Apr 4 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2023, April 04). What are public preferences for COVID-19 vaccine prioritization strategies across the globe?. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20210204/What-are-public-preferences-for-COVID-19-vaccine-prioritization-strategies-across-the-globe.aspx.

  • MLA

    Thomas, Liji. "What are public preferences for COVID-19 vaccine prioritization strategies across the globe?". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20210204/What-are-public-preferences-for-COVID-19-vaccine-prioritization-strategies-across-the-globe.aspx>.

  • Chicago

    Thomas, Liji. "What are public preferences for COVID-19 vaccine prioritization strategies across the globe?". News-Medical. https://www.news-medical.net/news/20210204/What-are-public-preferences-for-COVID-19-vaccine-prioritization-strategies-across-the-globe.aspx. (accessed November 24, 2024).

  • Harvard

    Thomas, Liji. 2023. What are public preferences for COVID-19 vaccine prioritization strategies across the globe?. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20210204/What-are-public-preferences-for-COVID-19-vaccine-prioritization-strategies-across-the-globe.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients